This is the first study that links the increment of CMKLR1 expression with insulin production, showing an association with fat mass and corporal dimensions, while the increased serum levels of chemerin in obesity were observed, favoring a dysmetabolic response. The gene discussed is CMKLR1; the disease is obesity due to melanocortin 4 receptor deficiency.